Biological Markers for Professional COPD (MB2PROF)
Marqueurs Biologiques Des Bronchopneumopathies Chroniques Obstructives Professionnelles
Chronic obstructive pulmonary disease (COPD) is a frequent disease, mainly linked to tobacco smoking leading to chronic respiratory failure. It is characterized by an inflammatory spate with modification of protease-antiprotease and oxidant-antioxydant balances. Local modifications are associated with systemic changes. Many occupational factors have been associated with an excess of COPD in epidemiological studies, however without identification of any specific clinical or biological phenotype.
Pathophysiological pathways involved in COPD might be different according to etiologic agents. Therefore, it is important to focus research on blood biomarkers associated with some well-characterized occupational COPD.
The objectives of MB2PROF project are:
- To build the first multicentric cohort of cases of occupational COPD, with collection of plasma and DNA samples,
- To study the evolution of clinical and lung function parameters of occupational COPD in comparison with non occupational COPD during a follow-up study,
- To identify biological phenotypes of COPD associated to a given etiological agent.
The methodology includes:
The constitution of a cohort with a clinical and biological follow-up during 5 years. Subjects will be recruited in 7 occupational diseases departments, with the collaboration of Pneumology departments.
Four groups of males subjects will be recruited (G1 : occupational COPD (6 groups of 60 subjects, corresponding to 6 groups of occupational agents) ; G2 : non occupational COPD (n = 60) ; G3 : subjects with similar occupational exposure to G1 subjects but without COPD (6 groups of 60 subjects) ; G4 : subjects free of occupational exposure and of COPD (n = 60)), paired on tobacco-smoking and age. For each subject, information on clinical data, lung function parameters, occupation history and blood samples will be collected.
- The identification of biomarkers, using proteomic and genomic approaches according to subgroups (with different etiologies) of occupational COPD,
- The study of molecular pathways identified in these subgroups, with in vitro and in vivo studies The MB2PROF project is an original and ambitious multidisciplinary and translational project. The constitution of well-characterized COPD cases cohort should allow the identification of biomarkers and molecular pathways associated with some subgroup of subjects, and improve the knowledge of mechanisms involved.
研究概览
地位
条件
研究类型
注册 (预期的)
联系人和位置
学习地点
-
-
-
Créteil、法国、94000
- 招聘中
- Chi Creteil
-
接触:
- Pascal Andujar, MD PhD
- 电话号码:33 1 57 02 20 95
- 邮箱:pascal.andujar@chicreteil.fr
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- COPD
Exclusion Criteria:
- Other obstructive disease
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
|---|
|
控件
|
|
慢性阻塞性肺病
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
C Protein Reactive
大体时间:at year 1
|
at year 1
|
|
blood inflammatory markers
大体时间:at year 1
|
at year 1
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
C Protein Reactive
大体时间:every year during 5 years
|
every year during 5 years
|
|
blood inflammatory markers
大体时间:every year during 5 years
|
every year during 5 years
|
合作者和调查者
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
慢性阻塞性肺病的临床试验
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...完全的
-
University College, LondonUniversity of Cambridge; National Institute for Health Research, United Kingdom; Royal Free Hampstead...未知
-
Virginia Commonwealth UniversityFisher and Paykel Healthcare完全的
-
AstraZeneca完全的